CPT® 0691U, Under Proprietary Laboratory Analyses
The Current Procedural Terminology (CPT®) code 0691U as maintained by American Medical Association, is a medical procedural code under the range - Proprietary Laboratory Analyses.
Get the full picture on this code.
Start a FREE 2-WEEK TRIAL of Codify by AAPC.
Tabs
Summary
This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0691U only for Horizon™ 5 from Natera™ Inc. This carrier screening test uses a genomic sequence analysis panel of six genes: CFTR, SMN1, HBB, HBA1, HBA2, and DMD. The test screens for carrier status related to cystic fibrosis, spinal muscular atrophy, beta hemoglobinopathies including sickle cell disease, alpha thalassemia, and Duchenne muscular dystrophy.
For clinical responsibility, terminology, tips and additional info
start codify free trial.
View any code changes for 2026 as well as historical information on code creation and revision.
Tabs
Combat the #1 denial reason - mismatched CPT-ICD-9 codes - with top Medicare carrier and private payer accepted diagnoses for the chosen CPT® code.
View the CPT® code's corresponding procedural code and DRG. In a click, check the DRG's IPPS allowable, length of stay, and more. To plug inpatient facility revenue drains, subscribe to DRG Coder today.
Crosswalk to an anesthesia code and its base units, and calculate payments in a snap! Subscribe to Anesthesia Coder today.
View matching HCPCS Level II codes and their definitions.
Read a CPT® Assistant article by subscribing to Code Connect Today!
Search across Medicare Manuals, Transmittals, and more. For FREE Trial, register now!